These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21034394)

  • 1. Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure.
    Towers KA; Bardsley KA; Macdonald PS
    Med J Aust; 2010 Nov; 193(9):555. PubMed ID: 21034394
    [No Abstract]   [Full Text] [Related]  

  • 2. Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients.
    Shimoyama N; Shimoyama M
    J Pain Symptom Manage; 2002 Jan; 23(1):73-6. PubMed ID: 11779672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice.
    Crawford RJ; Allman S; Gibson W; Kitchen S; Richards HH
    J Int Med Res; 1988; 16(2):143-9. PubMed ID: 3378660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants.
    Prabhu VG; Keszler M; Dhanireddy R
    Arch Dis Child Fetal Neonatal Ed; 1997 Jul; 77(1):F32-5. PubMed ID: 9279180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we improve the treatment of congestion in heart failure?
    Metra M; Bugatti S; Bettari L; Carubelli V; Danesi R; Lazzarini V; Lombardi C; Cas LD
    Expert Opin Pharmacother; 2011 Jun; 12(9):1369-79. PubMed ID: 21342081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer.
    Wilcock A; Walton A; Manderson C; Feathers L; El Khoury B; Lewis M; Chauhan A; Howard P; Bell S; Frisby J; Tattersfield A
    Thorax; 2008 Oct; 63(10):872-5. PubMed ID: 18408049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure.
    Newton PJ; Davidson PM; Krum H; Ollerton R; Macdonald P
    Heart Lung Circ; 2012 May; 21(5):260-6. PubMed ID: 22503786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: nebulized furosemide for dyspnea in terminal cancer patients.
    Stone P; Rix ; Kurowska A; Tookman
    J Pain Symptom Manage; 2002 Sep; 24(3):274-5; author reply 275-6. PubMed ID: 12458098
    [No Abstract]   [Full Text] [Related]  

  • 9. Nebulized frusemide for dyspnoea.
    Stone P; Kurowska A; Tookman A
    Palliat Med; 1994; 8(3):258. PubMed ID: 7952379
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea.
    Kohara H; Ueoka H; Aoe K; Maeda T; Takeyama H; Saito R; Shima Y; Uchitomi Y
    J Pain Symptom Manage; 2003 Oct; 26(4):962-7. PubMed ID: 14575057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous diuretic day-care treatment for patients with heart failure.
    Banerjee P; Tanner G; Williams L
    Clin Med (Lond); 2012 Apr; 12(2):133-6. PubMed ID: 22586787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid response to inhaled frusemide in severe acute asthma with hypercapnia.
    Tanigaki T; Kondo T; Hayashi Y; Katoh H; Kamio K; Urano T; Ohta Y
    Respiration; 1997; 64(1):108-10. PubMed ID: 9044485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
    Andrews R; Charlesworth A; Evans A; Cowley AJ
    Eur Heart J; 1997 May; 18(5):852-7. PubMed ID: 9152656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A response-adaptive design of initial therapy for emergency department patients with heart failure.
    Wen S; Ning J; Collins S; Berry D
    Contemp Clin Trials; 2017 Jan; 52():46-53. PubMed ID: 27838474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unclear lactate acidosis in a patient with heart failure under long-term diuretic therapy].
    Duell T; Mittermüller J; Hiddemann W
    Dtsch Med Wochenschr; 2000 Oct; 125(41):1232-4. PubMed ID: 11076262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant.
    Shiraishi M; Murakami T; Nawa T; Kobayashi H; Nagamine H; Shiraga K; Higashi K; Nakajima H
    Int J Cardiol; 2016 Jul; 215():127-8. PubMed ID: 27111174
    [No Abstract]   [Full Text] [Related]  

  • 17. A new visual analogue scale for assessment of dyspnoea in congestive heart failure.
    Subratty AH; Manraj M; Baligadoo S
    Int J Clin Pharmacol Ther; 1994 May; 32(5):259-61. PubMed ID: 7921521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy can achieve striking reductions in frusemide dosage.
    Jolobe OM
    Cardiology; 2009; 114(4):271; author reply 272. PubMed ID: 19684397
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral metolazone plus frusemide for home therapy in patients with refractory heart failure.
    Lancet; 1989 Apr; 1(8640):727-8. PubMed ID: 2564538
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in the pharmacological management of breathlessness.
    Currow DC; Ward AM; Abernethy AP
    Curr Opin Support Palliat Care; 2009 Jun; 3(2):103-6. PubMed ID: 19333124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.